TD Waterhouse Canada »

Rapport Therapeutics shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.8k 123 39.39

More positions owned by TD Waterhouse Canada

Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Apple (AAPL)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Enbridge (ENB)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Tc Energy Corp (TRP)
Manulife Finl Corp (MFC)
Canadian Natural Resources (CNQ)
JPMorgan Chase & Co. (JPM)
Suncor Energy (SU)
Brookfield Corp Cl A Ltd Vt Sh (BN)

View all positions for TD Waterhouse Canada

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Goldman Sachs Group
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vanguard Capital Management
Trv Gp Vi
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rapport Therapeutics